Christine R. Coyne - 01 Jul 2025 Form 4 Insider Report for Iterum Therapeutics plc (ITRM)

Role: Chief Commercial Officer
Signature: /s/ Christine R. Coyne
Issuer symbol: ITRM
Transactions as of: 01 Jul 2025
Net transactions value: $0
Form type: 4
Filing time: 03 Jul 2025, 16:16:04 UTC
Previous filing: 08 Feb 2022
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Coyne Christine	Chief Commercial Officer	C/O 25 NORTH WALL QUAY, DUBLIN 1, IRELAND	/s/ Christine R. Coyne	03 Jul 2025	0001861840

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ITRM	Share Option (Right to Buy)	Award	$0	+200,000		$0.000000	200,000	01 Jul 2025	Ordinary Shares	200,000	$0.9700	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The shares underlying this option shall vest at a rate of twenty-five percent of the total number of shares on the one-year anniversary of July 1, 2025 and the remaining 75% will vest in equal monthly installments thereafter until July 1, 2029, subject to the Reporting Person providing continuous service to the Issuer on each relevant vesting date.